These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 10050479)

  • 1. [The efficacy of treating patients with destructive pulmonary tuberculosis with liver involvement].
    Novozhylova IO
    Lik Sprava; 1998; (7):121-3. PubMed ID: 10050479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Use of the plant hepatoprotector Galstena tuberculostatics-induced hepatic lesions: experimental and clinical study].
    Katikova OIu; Asanov BM; Vize-Khripunova MA; Burba EN; Ruzov VI
    Probl Tuberk; 2002; (4):32-6. PubMed ID: 12125250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)].
    Mbaye PS; Talarmin F; Sane M; Eladari D; Klotz F
    Dakar Med; 1995; 40(2):129-31. PubMed ID: 9827070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Combined chemotherapy of toxic hepatitis in patients with pulmonary tuberculosis].
    Frolov VM; Peresadin NA; Pustovoĭ IuG
    Probl Tuberk; 1992; (5-6):30-1. PubMed ID: 1409510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ciprofloxacin in the management of pulmonary tuberculosis in the face of hepatic dysfunction.
    Yew WW; Chau CH; Wong PC; Lee J; Wong CF; Cheung SW; Chan CY; Cheng AF
    Drugs Exp Clin Res; 1995; 21(2):79-83. PubMed ID: 7555613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the hepatotoxic effect of antituberculous drugs in tuberculosis patients abusing alcohol.
    Grymiński J; Lyczewska J; Styszewska H; Walczak J
    Pol Med J; 1970; 9(3):635-44. PubMed ID: 5452841
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hepatic functional changes induced by the combined use of isoniazid, pyrazinamide and rifampicin in the treatment of pulmonary tuberculosis].
    de Souza AF; de Oliveira e Silva A; Baldi J; de Souza TN; Rizzo PM
    Arq Gastroenterol; 1996; 33(4):194-200. PubMed ID: 9302332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A prospective clinical study of isoniazid-rifampicin-pyrazinamide-induced liver injury in an area endemic for hepatitis B.
    Hwang SJ; Wu JC; Lee CN; Yen FS; Lu CL; Lin TP; Lee SD
    J Gastroenterol Hepatol; 1997 Jan; 12(1):87-91. PubMed ID: 9076631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinico-immunological variants of drug-induced toxic hepatitis in pulmonary tuberculosis patients].
    Frolov VM; Peresadin NA; Petrunia AM
    Probl Tuberk; 1993; (6):17-9. PubMed ID: 8290522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The effect of the preparation Wobenzym on the antioxidant protection indices and on the functional-morphological properties of the erythrocytes in a toxic lesion of the liver].
    Kolomoiets MIu; Shorikov IeI
    Lik Sprava; 1999 Jul; (5):124-8. PubMed ID: 10822699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Liver injury under tuberculostatic treatment].
    Fattinger K; Braunschweig S; Reichen J; Meier-Abt PJ; Krähenbühl S
    Praxis (Bern 1994); 1997 Apr; 86(15):626-9. PubMed ID: 9213916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of Astragalus dasyanthus in lesions of the liver in patients with pulmonary tuberculosis].
    Skakun NP; Blikhar EI; Oleĭnik AN
    Vrach Delo; 1988 Jun; (6):51-4. PubMed ID: 3420913
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hepatic jaundice in patients with pulmonary tuberculosis treated with various combinations of antitubercular drugs].
    Kubiak Z
    Gruzlica; 1968 Oct; 36(11):1133-5. PubMed ID: 5710701
    [No Abstract]   [Full Text] [Related]  

  • 14. Hepatotoxicity to different antituberculosis drug combinations.
    Aziz S; Agha F; Hassan R; Fairoz SA; Hassan K
    J Pak Med Assoc; 1990 Dec; 40(12):290-4. PubMed ID: 2126569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Liver function tests during treatment of tuberculosis with short-course regimens containing isoniazid, rifampicin & pyrazinamide.
    Swamy R; Acharyulu GS; Duraipandian M; Jawahar MS; Ramachandran R; Sarma GR
    Indian J Med Res; 1987 Nov; 86():549-57. PubMed ID: 3451899
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pharmacokinetic bases for the drug-free prevention of drug-induced hepatitis in pulmonary tuberculosis patients].
    Koriakin VA; Sokolova GB; Ziia AV; Zeliger LR; Ivleva AIa
    Ter Arkh; 1987; 59(7):75-7. PubMed ID: 3672366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Drug-induced hepatitis in pulmonary tuberculosis patients].
    Koriakin VIa; Sokolova GB; Ziia AV; Zeliger LR; Glik MS
    Vrach Delo; 1984 May; (5):60-2. PubMed ID: 6741089
    [No Abstract]   [Full Text] [Related]  

  • 18. [Ultrasonic examination of the liver in patients with pulmonary tuberculosis].
    Ivanov AK; Dzodzuashvili KA
    Klin Med (Mosk); 1990 Jan; 68(1):100-3. PubMed ID: 2186199
    [No Abstract]   [Full Text] [Related]  

  • 19. Alcoholic hepatic impairment complicating treatment with hepatotoxic antituberculosis drugs.
    Tiwari VK
    J Indian Med Assoc; 1996 Sep; 94(9):347-8. PubMed ID: 9019083
    [No Abstract]   [Full Text] [Related]  

  • 20. [On the problem of chronic liver damage following drug therapy of tuberculosis].
    Petera V; Klapálek D; Paichl P; Pecený A
    Dtsch Z Verdau Stoffwechselkr; 1965 Oct; 25(4):250-2. PubMed ID: 5888913
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.